Overview

CANPOS is a non-interventional study aiming at evaluate at the time of initial surgery the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer. This would represent a rational to develop personalized follow-up and prevention strategies

Eligibility

Inclusion Criteria:

• patients with a diagnosis or suspected for a diagnosis of lung cancer, non-small cell lung cancer
• age over 18 years
• patient naïve of any oncology treatment (excluding surgery alone) within the past 5 years
• patient who signed the informed consent by the study protocol

Exclusion criteria were:

• any ongoing treatment for cancer
• any history of cancer within 5 years before the diagnosis of lung cancer
• any psychological, sociological or geographical conditions that would not allow the study follow-up